Posters - NCDEU: An Annual Meeting Sponsored by ASCP
Posters - NCDEU: An Annual Meeting Sponsored by ASCP
Posters - NCDEU: An Annual Meeting Sponsored by ASCP
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
80<br />
<strong>Posters</strong><br />
64. Cognitive Performance in Patients with Schizophrenia Treated<br />
with Lurasidone: Results from a 6-week Core Study and 6-month<br />
Double-blind Extension<br />
Philip Harvey, University of Miami Miller School of Medicine<br />
Cynthia Siu, Josephine Cucchiaro, <strong>An</strong>tony Loebel<br />
65. A Pilot Study of Cognitive Remediation in a Forensic Setting<br />
<strong>An</strong>thony Ahmed, Georgia Health Sciences University<br />
66. The Impact of Study Design in Comparative Effectiveness<br />
Research in Schizophrenia<br />
Bruce Wong, Bruce Wong Consulting<br />
Noam Kirson, Yermakov Sander, Wayne Huang, Thomas Samuelson,<br />
Steve Offord, Greenberg Paul<br />
67. Switching to Lurasidone in Schizophrenia: Tolerability and<br />
Effectiveness of Three Strategies<br />
Josephine Cucchiaro, Sunovion Pharmaceuticals Inc.<br />
Joseph McEvoy, Leslie Citrome, David Hernandez, Joseph Severs,<br />
<strong>An</strong>tony Loebel<br />
68. Evaluation of the Accuracy of Applying Item Response Theory<br />
(IRT) Linking to an Abbreviated Version of the Positive and<br />
Negative Syndrome Scale (PANSS) for Evaluation and Refinement<br />
<strong>An</strong>zalee Khan, Nathan S. Kline Institute for Psychiatric Research<br />
Jean-Pierre Lindenmayer, Charles Lewis, Saurabh Kaushik<br />
69. Safety and Tolerability of Cariprazine in the Long-Term Treatment<br />
of Schizophrenia: Results From a 48-Week Extension Study<br />
<strong>An</strong>drew Cutler, Florida Clinical Research Center, LLC<br />
<strong>An</strong>jana Bose, Suresh Durgam, Raffaele Migliore, Qing Wang, Adam<br />
Ruth, György Németh, István Laszlovszky<br />
70. The Effect of the á2-adrenergic Receptor <strong>An</strong>tagonist Fluparoxan<br />
on a COMT-Val-tg Mouse Model of Cognitive Dysfunction<br />
Ayana Gibbs, University of Sussex<br />
71. New Results Alter Balance of Evidence of Long-Acting Injectable<br />
vs. Oral <strong>An</strong>tipsychotics Regarding Relapse Prevention in<br />
Schizophrenia: A Systematic Review and Meta-<strong>An</strong>alysis<br />
Taishiro Kishimoto, The Zucker Hillside Hospital<br />
Alfred Robenzadeh, Claudia Leucht, Stefan Leucht, Koichiro<br />
Watanabe, Masaru Mimura, John Kane, Christoph Correll<br />
= New Investigator Q Pharmaceutical Pipeline
Change language